Drugs / Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid
Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid
also known as
Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05856578 | Mar 2022 → May 2023 | type 2 diabetes mellitus | Nanjing First Hospital, Nanjing Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05856578 ↗ |
| Known as | Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet | “Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid” NCT05856578 ↗ |
| Route | Oral | “Mulberry Twig (Ramulus Mori, Sangzhi) Alkaloid Tablet 50mg po tid” NCT05856578 ↗ |